Claritev Corporation, formerly known as MultiPlan, reported a decrease in revenues to $232.1 million and a net loss of $138.0 million for Q4 2024. The company is celebrating its rebranding launch and focusing on making healthcare more affordable.
Revenues for Q4 2024 were $232.1 million, a decrease of 4.9% compared to the previous year.
Net loss for Q4 2024 was $138.0 million, compared to a net loss of $31.4 million in the same quarter of the previous year.
Adjusted EBITDA for Q4 2024 was $141.6 million, compared to $156.8 million in the previous year.
The company ended Q4 2024 with $16.8 million in unrestricted cash and cash equivalents.
Claritev anticipates revenue to be (2)% to flat as compared to FY 2024 and FY 2025 Adjusted EBITDA % guidance of 62.5% to 63.5%.
Analyze how earnings announcements historically affect stock price performance